Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Vulvodynia: early-phase trial registry

3 of 10 indexed Vulvodynia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Vulvodynia: 10 US clinical trials tracked, 3 recruiting.

Vulvodynia is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Kenneth Peters, MD, running 1 of these trials.

Enrollment posture brief

Registry condition vulvodynia

OPEN 3 | RECR 30% | LATE 1 | EARLY 2 | RANK #1724 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Vulvodynia (this)30%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Vulvodynia

Vulvodynia lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vulvodynia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vulvodynia is recruiting below its size-band peers.

    3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Vulvodynia trials is spread across many organizations.

    Kenneth Peters, MD accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Vulvodynia trials plan to enrol fewer than 100 people.

    Median target enrolment is 54 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.

  4. Vulvodynia research is mostly interventional.

    7 interventional and 3 observational studies make up this index (70% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1

Top Sponsors

Kenneth Peters, MD 1 trials
Schlaeger, Judith M., CNM, LAc, PhD 1 trials
Center for Vulvovaginal Disorders 1 trials
Texas Tech University Health Sciences Center 1 trials
University of Tennessee 1 trials
OHSU Knight Cancer Institute 1 trials
University of Illinois at Chicago 1 trials
Ipsen 1 trials
University of California, Los Angeles 1 trials
Oregon Health and Science University 1 trials

Named interventions

Most-linked intervention names on Vulvodynia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Topical liquid lidocaine Drug
1 trials
CC-10004 Drug
1 trials
Placebo Acupuncture Other
1 trials
Active Acupuncture Other
1 trials
Placebo (Vehicle Cream) Drug
1 trials
Ketotifen Fumarate 0.25% Cream Drug
1 trials
Topical saline Drug
1 trials
Traditional Technique Other
1 trials

US sites by state

Facility locations filed on Vulvodynia trials. A trial with sites in several states counts in each.

New York 3 trials
Oregon 2 trials
Illinois 2 trials
District of Columbia 2 trials
California 2 trials
Texas 1 trials
Tennessee 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vulvodynia page

10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vulvodynia condition card totals 10 registered trials; most-linked intervention Topical liquid lidocaine; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.